28.1 μg/dL; p = 0.002) median together with an increasing trend of vitamin E (1316 vs. 1181 μg/dL; n.s.).
← all excerpts
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment.
2
—
—
The sentences
47 mg/dL; p = 0.0001), while a decreasing trend of cholesterol of high-density lipoproteins (HDL) was observed (49 vs. 56 mg/dL; not significant, n.s.).